Business Case Studies, Value Chain Analysis Case Study, Big Pharma R&D,Is it worth spending?

print page
Tell A Friend
Bookmark
 

Case Categories

Value Chain Analysis Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Big Pharma R&D: Is it worth spending?

Publication Year : 2004

Authors: B N Renuka Prasad, Christoph

Industry: Health Care

Region:USA

Case Code: VCA0002

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
Big Pharma like Pfizer, Glaxo and Novartis spend as much as $30 billion a year on R&D. But the number of new molecular entities resulting from such R&D spend is shrinking.

Pedagogical Objectives:

  • To highlight the decreasing number of new molecular entities
  • To discuss the other challenges faced by today's Big Pharma.

Keywords : Big pharma; R&D; Pfizer; Novartis; New molecular entities; Eli Lilly; Astrazeneca; Bristol-Myers Squibb; Sanofi-Synthelabo; Industry Analysis Case Study; Schering-Plough; Merck; Pharmaceutical; GlaxoSmithKline; USFDA; Drugs

Contents:

  • Introduction
  • Challenges
  • Conclusion

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • David ConklinDavid Conklin

    David Conklin, is a professor at the Richard Ivey School of Business
    Speaks on Government and Business
  • Lord Meghnad DesaiLord Meghnad Desai

    Lord Meghnad Desai, is an Indian-born British economist and Labor politician
    Speaks on Government and Business
  • Vijay GovindarajanVijay Govindarajan

    Vijay Govindarajan, is widely regarded as one of the world’s leading experts on strategy and innovation
    Speaks on Reverse Innovation
  • View All Executive Interviews»






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674
E-mail: casehelpdesk@ibsindia.org

©2003-2010 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap